Appointed 2021.
Anna has a PhD in Pharmaceutical Biosciences. More than 15 years of experience from pharmaceutical industry, regulatory authority and as business advisor at Uppsala University Innovation.
Holdings in the company: 0 shares and 84,263 employee warrants.